Klinikum Frankfurt Höchst GmbH

Frankfurt am Main 65929

0 studies enrolling now · 2 studies all time

What they study most

Metastatic gpNMB Over-expressing Triple Negative Breast Cancer, Myocardial Infarction

Studies at this site

• EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction) — Completed
• Study of Glembatumumab Vedotin (CDX-011) in Patients With Metastatic, gpNMB Over-Expressing, Triple Negative Breast Cancer — Completed